Coloplast A/S (CPH:COLO.B)
435.50
+15.40 (3.67%)
Jul 28, 2026, 4:59 PM CET
Coloplast Market Cap
Coloplast has a market cap or net worth of 98.06 billion as of July 28, 2026. Its market cap has decreased by -29.58% in one year.
Market Cap
98.06B
Enterprise Value
121.22B
Revenue
28.05B
Ranking
n/a
PE Ratio
46.62
Stock Price
435.50
ChartMarket Cap Chart
Since November 17, 1997, Coloplast's market cap has increased from 5.88B to 98.06B, an increase of 1,567.69%. That is a compound annual growth rate of 10.30%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 28, 2026 | 98.06B | -20.37% |
| Dec 30, 2025 | 123.14B | -30.43% |
| Dec 30, 2024 | 177.00B | 2.05% |
| Dec 29, 2023 | 173.44B | 0.54% |
| Dec 30, 2022 | 172.51B | -29.57% |
| Dec 30, 2021 | 244.93B | 23.89% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.44T |
| Genmab | 117.14B |
| Demant | 58.71B |
| ALK-Abelló | 49.98B |
| H. Lundbeck | 40.31B |
| Zealand Pharma | 20.52B |
| Ambu A/S | 18.50B |
| GN Store Nord | 13.67B |